Expert Series: Why is Early Access important to families living with a rare disease?
Early access is often the only treatment option for patients living with a rare disease, but often due to compliance, it is not discussed. Join MitoAction and Naomi Litchfield, Director of Patient Advocacy at Bionical Emas, to discuss the history, laws, risks, benefits, terminology, and request process of early access to an investigational medicine.
